Stay updated on Oral PHA-022121 Dose-ranging Clinical Trial
Sign up to get notified when there's something new on the Oral PHA-022121 Dose-ranging Clinical Trial page.

Latest updates to the Oral PHA-022121 Dose-ranging Clinical Trial page
- Check6 days agoChange DetectedThe study history now shows a new version (v3.6.3) with Results Submitted, indicating that results for the trial have been submitted. The previous No Results Posted state and revision v3.6.2 are superseded by this update.SummaryDifference0.1%

- Check13 days agoChange DetectedRevision updated to v3.6.2, indicating an updated build of the ClinicalTrials.gov interface. This change reflects a backend/UI deployment rather than any new or removed study data on the page.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe study is no longer looking for participants, indicating recruitment has closed. The record version has been updated to v3.6.0, replacing the previous v3.5.5 entry.SummaryDifference0.3%

- Check34 days agoChange DetectedThe history view now shows a new revision label v3.5.5, replacing the previous v3.5.4. This reflects a minor platform update to the history metadata rather than any study content.SummaryDifference0.1%

- Check56 days agoChange DetectedRevision: v3.5.4 replaces the previous revision (v3.5.3) on the page, signaling a backend platform update. It does not modify study data or other user-facing content.SummaryDifference0.1%

- Check77 days agoChange DetectedUpdated the displayed revision/version number on the ClinicalTrials.gov page from v3.5.2 to v3.5.3.SummaryDifference0.1%

Stay in the know with updates to Oral PHA-022121 Dose-ranging Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral PHA-022121 Dose-ranging Clinical Trial page.